$PCRX
Pacira Biosciences Inc

2020 Q2 Form 10-Q Financial Statement

#000139681420000029 Filed on August 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2 2019 Q1
Revenue $75.51M $102.6M $91.31M
YoY Change -26.41% 21.99% 22.39%
Cost Of Revenue $22.31M $25.20M $27.30M
YoY Change -11.49% 20.49% 19.31%
Gross Profit $53.20M $77.40M $64.01M
YoY Change -31.27% 22.49% 23.76%
Gross Profit Margin 70.46% 75.44% 70.1%
Selling, General & Admin $43.34M $49.13M $47.31M
YoY Change -11.77% 11.02% 7.05%
% of Gross Profit 81.47% 63.47% 73.9%
Research & Development $13.62M $17.83M $14.38M
YoY Change -23.6% 45.66% 0.04%
% of Gross Profit 25.6% 23.03% 22.47%
Depreciation & Amortization $3.000M $3.500M $3.600M
YoY Change -14.29% 25.0% 30.34%
% of Gross Profit 5.64% 4.52% 5.62%
Operating Expenses $56.96M $97.33M $90.23M
YoY Change -41.47% 25.48% 10.66%
Operating Profit -$7.147M $5.275M $1.079M
YoY Change -235.49% -19.35% -115.55%
Interest Expense $5.456M $5.878M $5.814M
YoY Change -7.18% 8.91% 12.74%
% of Operating Profit 111.43% 538.83%
Other Income/Expense, Net -$164.0K -$4.148M -$3.597M
YoY Change -96.05% 5.23% -2.99%
Pretax Income -$7.311M $1.127M -$2.518M
YoY Change -748.71% -56.64% -76.35%
Income Tax -$42.00K -$1.600M $253.0K
% Of Pretax Income -141.97%
Net Earnings -$7.269M $2.730M -$2.771M
YoY Change -366.26% 6.47% -74.05%
Net Earnings / Revenue -9.63% 2.66% -3.03%
Basic Earnings Per Share -$0.17 $0.07 -$0.07
Diluted Earnings Per Share -$0.17 $0.06 -$0.07
COMMON SHARES
Basic Shares Outstanding 42.22M shares 41.38M shares 41.24M shares
Diluted Shares Outstanding 42.22M shares 42.35M shares 41.24M shares

Balance Sheet

Concept 2020 Q2 2019 Q2 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $326.8M $292.2M $412.4M
YoY Change 11.84% -21.3% 21.37%
Cash & Equivalents $78.55M $59.74M $215.0M
Short-Term Investments $248.2M $232.5M $197.4M
Other Short-Term Assets $18.30M $8.500M $9.400M
YoY Change 115.29% 41.67% 22.08%
Inventory $66.69M $52.70M $47.03M
Prepaid Expenses
Receivables $44.01M $41.15M $39.77M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $455.8M $394.6M $508.7M
YoY Change 15.51% -13.28% 21.48%
LONG-TERM ASSETS
Property, Plant & Equipment $113.3M $105.5M $107.1M
YoY Change 7.4% -5.2% -1.99%
Goodwill $99.50M $100.5M $62.00M
YoY Change -1.03% 67.81% 7.84%
Intangibles $100.5M $108.3M
YoY Change -7.26%
Long-Term Investments $10.00M $42.40M $14.10M
YoY Change -76.42% 170.06% -60.61%
Other Assets $560.0K
YoY Change -26.22%
Total Long-Term Assets $410.3M $393.2M $210.5M
YoY Change 4.34% 109.58% 3.53%
TOTAL ASSETS
Total Short-Term Assets $455.8M $394.6M $508.7M
Total Long-Term Assets $410.3M $393.2M $210.5M
Total Assets $866.1M $787.8M $719.2M
YoY Change 9.93% 22.59% 15.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.160M $13.35M $13.37M
YoY Change -31.37% -6.4% -10.35%
Accrued Expenses $47.68M $51.91M $39.70M
YoY Change -8.14% 35.05% 20.23%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $70.58M $83.00M $58.99M
YoY Change -14.96% 56.54% 21.96%
LONG-TERM LIABILITIES
Long-Term Debt $314.2M $298.2M $294.4M
YoY Change 5.37% 5.26% 5.26%
Other Long-Term Liabilities $2.984M $8.993M $8.993M
YoY Change -66.82% -43.39% -41.84%
Total Long-Term Liabilities $2.984M $8.993M $8.993M
YoY Change -66.82% -43.39% -41.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $70.58M $83.00M $58.99M
Total Long-Term Liabilities $2.984M $8.993M $8.993M
Total Liabilities $478.0M $446.2M $391.6M
YoY Change 7.12% 26.7% 14.01%
SHAREHOLDERS EQUITY
Retained Earnings -$398.5M -$388.4M -$391.2M
YoY Change 2.6% -1.88% -1.83%
Common Stock $43.00K $42.00K $41.00K
YoY Change 2.38% 2.44% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 0.000 shares 0.000 shares
Shareholders Equity $388.1M $341.7M $327.5M
YoY Change
Total Liabilities & Shareholders Equity $866.1M $787.8M $719.2M
YoY Change 9.93% 22.59% 15.61%

Cashflow Statement

Concept 2020 Q2 2019 Q2 2019 Q1
OPERATING ACTIVITIES
Net Income -$7.269M $2.730M -$2.771M
YoY Change -366.26% 6.47% -74.05%
Depreciation, Depletion And Amortization $3.000M $3.500M $3.600M
YoY Change -14.29% 25.0% 30.34%
Cash From Operating Activities -$15.63M $22.76M $3.499M
YoY Change -168.67% 66.01% -230.07%
INVESTING ACTIVITIES
Capital Expenditures -$8.910M -$2.050M $2.018M
YoY Change 334.63% -22.35% -61.07%
Acquisitions
YoY Change
Other Investing Activities $45.03M -$179.8M $80.50M
YoY Change -125.05% -388.94% -1675.34%
Cash From Investing Activities $36.13M -$181.8M $78.48M
YoY Change -119.87% -405.19% -862.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.460M 3.740M $530.0K
YoY Change -7.49% 85.15% 26.49%
NET CHANGE
Cash From Operating Activities -15.63M 22.76M $3.499M
Cash From Investing Activities 36.13M -181.8M $78.48M
Cash From Financing Activities 3.460M 3.740M $530.0K
Net Change In Cash 23.96M -155.3M $82.51M
YoY Change -115.43% -306.24% 19592.12%
FREE CASH FLOW
Cash From Operating Activities -$15.63M $22.76M $3.499M
Capital Expenditures -$8.910M -$2.050M $2.018M
Free Cash Flow -$6.720M $24.81M $1.481M
YoY Change -127.09% 51.74% -118.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001396814
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201602Member
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35060
dei Entity Registrant Name
EntityRegistrantName
PACIRA BIOSCIENCES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
51-0619477
dei Entity Address Address Line1
EntityAddressAddressLine1
5 Sylvan Way, Suite 300
dei Entity Address City Or Town
EntityAddressCityOrTown
Parsippany
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07054
dei City Area Code
CityAreaCode
973
dei Local Phone Number
LocalPhoneNumber
254-3560
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
PCRX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
42742176 shares
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78552000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78228000 USD
CY2020Q2 us-gaap Short Term Investments
ShortTermInvestments
248240000 USD
CY2019Q4 us-gaap Short Term Investments
ShortTermInvestments
213722000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
44013000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
47530000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
66690000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
58296000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
18328000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10781000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
455823000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
408557000 USD
CY2020Q2 us-gaap Long Term Investments
LongTermInvestments
8261000 USD
CY2019Q4 us-gaap Long Term Investments
LongTermInvestments
64798000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
113297000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
104681000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
77799000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
38124000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
99547000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
99547000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
100454000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
104387000 USD
CY2020Q2 us-gaap Summary Of Investments Other Than Investments In Related Parties Carrying Amount
SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount
10930000 USD
CY2019Q4 us-gaap Summary Of Investments Other Than Investments In Related Parties Carrying Amount
SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount
10971000 USD
CY2020Q2 us-gaap Assets
Assets
866111000 USD
CY2019Q4 us-gaap Assets
Assets
831065000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
9160000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12799000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
47684000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
70427000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7620000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4935000 USD
CY2020Q2 pcrx Contingent Consideration Current
ContingentConsiderationCurrent
4504000 USD
CY2019Q4 pcrx Contingent Consideration Current
ContingentConsiderationCurrent
18179000 USD
CY2020Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
1615000 USD
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1333000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
70583000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
107673000 USD
CY2020Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
314182000 USD
CY2019Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
306045000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
73888000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
40938000 USD
CY2020Q2 pcrx Contingent Consideration Noncurrent
ContingentConsiderationNoncurrent
16326000 USD
CY2019Q4 pcrx Contingent Consideration Noncurrent
ContingentConsiderationNoncurrent
19963000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2984000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1502000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
477963000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
476121000 USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42608257 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42608257 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41908148 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41908148 shares
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
43000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
42000 USD
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
785124000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
753978000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-398509000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-399398000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1490000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
322000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
388148000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
354944000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
866111000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
831065000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
75505000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
102604000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
181189000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
193917000 USD
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
22305000 USD
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
25201000 USD
us-gaap Cost Of Revenue
CostOfRevenue
52037000 USD
us-gaap Cost Of Revenue
CostOfRevenue
52505000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13620000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17827000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29440000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32210000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
43342000 USD
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
49126000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
88122000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
96431000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1967000 USD
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1770000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3933000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1770000 USD
CY2020Q2 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
-1418000 USD
CY2019Q2 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
-3405000 USD
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
2290000 USD
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
-4647000 USD
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
82652000 USD
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
97329000 USD
us-gaap Costs And Expenses
CostsAndExpenses
171242000 USD
us-gaap Costs And Expenses
CostsAndExpenses
187563000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7147000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
5275000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
9947000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
6354000 USD
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1323000 USD
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1817000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
2911000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
3973000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
5456000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
5878000 USD
us-gaap Interest Expense
InterestExpense
11477000 USD
us-gaap Interest Expense
InterestExpense
11691000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3969000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-87000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-136000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-26000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-164000 USD
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4148000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8702000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7744000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7311000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1127000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1245000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1390000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-42000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1603000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
356000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1349000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-7269000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
2730000 USD
us-gaap Net Income Loss
NetIncomeLoss
889000 USD
us-gaap Net Income Loss
NetIncomeLoss
-41000 USD
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42221000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41384000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42126000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41312000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42221000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42345000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42861000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41312000 shares
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-7269000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
2730000 USD
us-gaap Net Income Loss
NetIncomeLoss
889000 USD
us-gaap Net Income Loss
NetIncomeLoss
-41000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2536000 USD
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
318000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1168000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
780000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2536000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
318000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1168000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
780000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4733000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3048000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2057000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
739000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
374036000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8202000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1421000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9222000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2536000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-7269000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
388148000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
327519000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2029000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1270000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7783000 USD
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
318000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
2730000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
341650000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
354944000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11656000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1421000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18070000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1168000 USD
us-gaap Net Income Loss
NetIncomeLoss
889000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
388148000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
321226000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3586000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1270000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15217000 USD
us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
-233000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
780000 USD
us-gaap Net Income Loss
NetIncomeLoss
-41000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
341650000 USD
us-gaap Net Income Loss
NetIncomeLoss
889000 USD
us-gaap Net Income Loss
NetIncomeLoss
-41000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9810000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8881000 USD
pcrx Amortization Of Other Assets And Unfavorable Lease Obligation
AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
883000 USD
pcrx Amortization Of Other Assets And Unfavorable Lease Obligation
AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
844000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
7254000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
6749000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-22000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-157000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
18070000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
15217000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-2312000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
8000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3517000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2141000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8394000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2519000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1701000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1163000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3517000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1321000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-21468000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1844000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-3052000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-245000 USD
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
9409000 USD
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9416000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
26262000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
118683000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15630000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4070000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
72263000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
141960000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
95450000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
163017000 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1622000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7557000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-103318000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6353000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3568000 USD
pcrx Proceedsfrom Shares Issued Under Employee Stock Purchase Plans
ProceedsfromSharesIssuedUnderEmployeeStockPurchasePlans
1421000 USD
pcrx Proceedsfrom Shares Issued Under Employee Stock Purchase Plans
ProceedsfromSharesIssuedUnderEmployeeStockPurchasePlans
1270000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
0 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
338000 USD
pcrx Conversionofprincipalandequitycomponentofconvertibleseniornotes
Conversionofprincipalandequitycomponentofconvertibleseniornotes
0 USD
pcrx Conversionofprincipalandequitycomponentofconvertibleseniornotes
Conversionofprincipalandequitycomponentofconvertibleseniornotes
233000 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
5591000 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2183000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4267000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
324000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-72789000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78228000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
132526000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78552000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59737000 USD
us-gaap Interest Paid Net
InterestPaidNet
4097000 USD
us-gaap Interest Paid Net
InterestPaidNet
4102000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
80000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
490000 USD
pcrx Increase Decrease In Contingent Consideration
IncreaseDecreaseInContingentConsideration
0 USD
pcrx Increase Decrease In Contingent Consideration
IncreaseDecreaseInContingentConsideration
28470000 USD
pcrx Increase Decreasein Accrued Fixed Assets
IncreaseDecreaseinAccruedFixedAssets
1115000 USD
pcrx Increase Decreasein Accrued Fixed Assets
IncreaseDecreaseinAccruedFixedAssets
682000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
75216000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
101824000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
179961000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
192730000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
180121000 USD
CY2020Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
23894000 USD
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
20019000 USD
CY2020Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
9699000 USD
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
14407000 USD
CY2020Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
33097000 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
23870000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
66690000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
58296000 USD
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
194514000 USD
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
81217000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
75440000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
113297000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
104681000 USD
CY2020Q2 us-gaap Depreciation
Depreciation
3000000.0 USD
CY2019Q2 us-gaap Depreciation
Depreciation
3500000 USD
us-gaap Depreciation
Depreciation
5900000 USD
us-gaap Depreciation
Depreciation
7100000 USD
CY2020Q2 pcrx Foreign Property Plantand Equipment Net
ForeignPropertyPlantandEquipmentNet
65400000 USD
CY2019Q4 pcrx Foreign Property Plantand Equipment Net
ForeignPropertyPlantandEquipmentNet
64800000 USD
CY2020Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
200000 USD
CY2020Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P10Y2M12D
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
2422000 USD
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1516000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
3986000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
2959000 USD
CY2020Q2 us-gaap Variable Lease Cost
VariableLeaseCost
601000 USD
CY2019Q2 us-gaap Variable Lease Cost
VariableLeaseCost
449000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
1049000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
829000 USD
CY2020Q2 us-gaap Lease Cost
LeaseCost
3023000 USD
CY2019Q2 us-gaap Lease Cost
LeaseCost
1965000 USD
us-gaap Lease Cost
LeaseCost
5035000 USD
us-gaap Lease Cost
LeaseCost
3788000 USD
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
8503000 USD
CY2019Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
3121000 USD
CY2020Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
42101000 USD
CY2019Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
38419000 USD
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y6M18D
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0688
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
7497000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
10745000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
10423000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
10697000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
10980000 USD
CY2020Q2 pcrx Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
62072000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
112414000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
30906000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
81508000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
99500000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
99500000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
110090000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9636000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
100454000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
110090000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5703000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
104387000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2000000.0 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3900000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1800000 USD
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1800000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
3900000 USD
CY2020Q2 pcrx Finite Lived Intangible Assets Amortization Expense Annual Amount Period1
FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1
7900000 USD
CY2020Q2 pcrx Finite Lived Intangible Assets Amortization Expense Annual Amount Period2
FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2
2200000 USD
pcrx Settlement Period Convertible Debt Conversion Request
SettlementPeriodConvertibleDebtConversionRequest
P40D
CY2020Q2 us-gaap Share Price
SharePrice
52.47
CY2019Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
CY2020Q2 pcrx Total Milestone Payments Yet To Be Paidin Connectionwith Myo Science Acquisition
TotalMilestonePaymentsYetToBePaidinConnectionwithMyoScienceAcquisition
58000000.0 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
255011000 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1490000 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
256501000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
278198000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
346000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
24000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
278520000 USD
CY2020Q2 us-gaap Interest Receivable
InterestReceivable
1700000 USD
CY2019Q4 us-gaap Interest Receivable
InterestReceivable
1400000 USD
CY2020Q2 us-gaap Equity Method Investments
EquityMethodInvestments
10000000.0 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
10000000.0 USD
CY2020Q2 us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
4000000.0 USD
us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
100000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9222000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7783000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18070000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15217000 USD
CY2020Q2 pcrx Compensationexpensefromstockoptionsemployees
Compensationexpensefromstockoptionsemployees
6388000 USD
CY2019Q2 pcrx Compensationexpensefromstockoptionsemployees
Compensationexpensefromstockoptionsemployees
5378000 USD
pcrx Compensationexpensefromstockoptionsemployees
Compensationexpensefromstockoptionsemployees
12614000 USD
pcrx Compensationexpensefromstockoptionsemployees
Compensationexpensefromstockoptionsemployees
10499000 USD
CY2020Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
2636000 USD
CY2019Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
2204000 USD
us-gaap Restricted Stock Expense
RestrictedStockExpense
5037000 USD
us-gaap Restricted Stock Expense
RestrictedStockExpense
4311000 USD
CY2020Q2 pcrx Compensationexpensefromemployeestockpurchaseplan
Compensationexpensefromemployeestockpurchaseplan
198000 USD
CY2019Q2 pcrx Compensationexpensefromemployeestockpurchaseplan
Compensationexpensefromemployeestockpurchaseplan
201000 USD
pcrx Compensationexpensefromemployeestockpurchaseplan
Compensationexpensefromemployeestockpurchaseplan
419000 USD
pcrx Compensationexpensefromemployeestockpurchaseplan
Compensationexpensefromemployeestockpurchaseplan
407000 USD
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
9222000 USD
CY2019Q2 us-gaap Share Based Compensation
ShareBasedCompensation
7783000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
18070000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
15217000 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6706378 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
42.80
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1346703 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
46.72
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
427606 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
27.26
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
150954 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
41.93
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
31982 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
61.24
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7442539 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.34
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
22.05
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.85
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
36668 shares
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-7269000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
2730000 USD
us-gaap Net Income Loss
NetIncomeLoss
889000 USD
us-gaap Net Income Loss
NetIncomeLoss
-41000 USD
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42221000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41384000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42126000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41312000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42221000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42345000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42861000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41312000 shares
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7522000 shares
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4616000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5533000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6538000 shares
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-6645000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
3760000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
6400000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
5580000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-666000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-2633000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-5155000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-6970000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7311000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1127000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1245000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1390000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1600000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
400000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1300000 USD
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-1800000 USD
CY2019Q2 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-1800000 USD
CY2019Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
CY2020Q2 us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
200000 USD
us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
100000 USD
CY2019Q2 us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
100000 USD
us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
100000 USD
CY2019Q4 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
3500000 USD

Files In Submission

Name View Source Status
0001396814-20-000029-index-headers.html Edgar Link pending
0001396814-20-000029-index.html Edgar Link pending
0001396814-20-000029.txt Edgar Link pending
0001396814-20-000029-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pcrx-20200630.htm Edgar Link pending
pcrx-20200630.xsd Edgar Link pending
pcrx-20200630_cal.xml Edgar Link unprocessable
pcrx-20200630_def.xml Edgar Link unprocessable
pcrx-20200630_g1.jpg Edgar Link pending
pcrx-20200630_htm.xml Edgar Link completed
pcrx-20200630_lab.xml Edgar Link unprocessable
pcrx-20200630_pre.xml Edgar Link unprocessable
pcrx-6302020xex311.htm Edgar Link pending
pcrx-6302020xex312.htm Edgar Link pending
pcrx-6302020xex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending